Home > Riviste > Minerva Medica > Fascicoli precedenti > Articles online first > Minerva Medica 2021 Dec 03

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Medica 2021 Dec 03

DOI: 10.23736/S0026-4806.20.07050-0

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?

Balint G. SZABO 1, 2 , Csaba LORINCZI 1, Judit SZANKA 1, Botond LAKATOS 1, Janos SINKO 1, Janos SZLAVIK 1, Gabor MIKALA 1

1 South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus, Budapest, Hungary; 2 School of PhD Studies, Semmelweis University, Budapest, Hungary


PDF


inizio pagina